Le Lézard
Classified in: Health
Subject: CCA

Labcorp to Announce Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024


BURLINGTON, N.C., Jan. 16, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the fourth quarter and full year 2023 before the market opens on Thursday, February 15, 2024. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.

The call will be webcast live on the Labcorp Investor Relations website. Participants may also register for the call by clicking on this link, to receive the dial-in numbers and unique PIN to access the call. The webcast and dial-in are listen-only. It is recommended that participants join 10 minutes prior to the start, although participants may register and join at any time during the call.

A replay of the webcast will be available approximately two hours after the conclusion of the live event, and will be available until Feb. 1, 2025. To access the webcast recording, visit the Labcorp Investor Relations website.

About Labcorp
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's more than 60,000 employees serve clients in over 100 countries, worked on over 80% of the new drugs approved by the FDA in 2022 and performed more than 600 million tests for patients around the world. Learn more about us at www.Labcorp.com.

SOURCE Laboratory Corporation of America Holdings


These press releases may also interest you

at 09:16
The Oxford-Harrington Rare Disease Centre ('OHC'), a partnership (between the University of Oxford, UK and Harrington Discovery Institute at University Hospitals, Cleveland, Ohio) aimed at driving cutting-edge rare disease breakthroughs, is pleased...

at 09:15
Morgan Scientific, an industry leader in PFT software that delivers advanced enterprise point-of-care solutions, today announced a strategic partnership with ZEPHYRx. The partnership brings ZEPHYRx's respiratory platform together with Morgan...

at 09:05
Whitefort Capital Management, LP (together with its affiliates, "Whitefort Capital," "us" or "we"), which is a long-term investor and the second largest shareholder of Arbutus Biopharma Corp. ("Arbutus" or the "Company") with an ownership interest...

at 09:05
ImmunityBio, Inc. today announced the publication of three podcasts with UroToday highlighting the company's recent FDA approval of ANKTIVA® (N-803, or nogapendekin alfa inbakicept-pmln) plus Bacillus Calmette-Guérin (BCG) for non-muscle invasive...

at 09:05
Halespring, a pioneering mental health technology startup, is excited to announce the opening of its crowdfunding campaign on WeFunder, the leading SEC regulated equity crowdfunding site. Halespring is dedicated to transforming the mental healthcare...

at 09:00
J.P. Morgan Life Sciences Private Capital, Blue Horizon Advisors and United Al Saqer Group today announced Rayees Rahman of Harmonic Discovery as the winner of the inaugural J.P. Morgan Asset Management: Life Sciences Innovation Summit. Harmonic...



News published on and distributed by: